H&E Equipment Services Statistics
Total Valuation
NeoGenomics has a market cap or net worth of $666.56 million. The enterprise value is $914.64 million.
Important Dates
The last earnings date was Tuesday, July 29, 2025, before market open.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NeoGenomics has 129.18 million shares outstanding. The number of shares has increased by 1.05% in one year.
Current Share Class | 129.18M |
Shares Outstanding | 129.18M |
Shares Change (YoY) | +1.05% |
Shares Change (QoQ) | +0.45% |
Owned by Insiders (%) | 1.22% |
Owned by Institutions (%) | 95.57% |
Float | 127.06M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 35.37 |
PS Ratio | 0.95 |
Forward PS | 0.84 |
PB Ratio | 0.78 |
P/TBV Ratio | 23.72 |
P/FCF Ratio | n/a |
P/OCF Ratio | 47.45 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.33 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.48.
Current Ratio | 3.92 |
Quick Ratio | 3.16 |
Debt / Equity | 0.48 |
Debt / EBITDA | 97.85 |
Debt / FCF | n/a |
Interest Coverage | -13.50 |
Financial Efficiency
Return on equity (ROE) is -11.76% and return on invested capital (ROIC) is -3.52%.
Return on Equity (ROE) | -11.76% |
Return on Assets (ROA) | -3.23% |
Return on Invested Capital (ROIC) | -3.52% |
Return on Capital Employed (ROCE) | -6.07% |
Revenue Per Employee | $313,268 |
Profits Per Employee | -$47,290 |
Employee Count | 2,200 |
Asset Turnover | 0.45 |
Inventory Turnover | 13.47 |
Taxes
Income Tax | -1.41M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.90% in the last 52 weeks. The beta is 1.62, so NeoGenomics's price volatility has been higher than the market average.
Beta (5Y) | 1.62 |
52-Week Price Change | -70.90% |
50-Day Moving Average | 6.99 |
200-Day Moving Average | 11.36 |
Relative Strength Index (RSI) | 29.52 |
Average Volume (20 Days) | 2,746,713 |
Short Selling Information
Short Interest | 4.27M |
Short Previous Month | 4.54M |
Short % of Shares Out | 3.31% |
Short % of Float | 3.36% |
Short Ratio (days to cover) | 2.18 |
Income Statement
In the last 12 months, NeoGenomics had revenue of $689.19 million and -$104.04 million in losses. Loss per share was -$0.82.
Revenue | 689.19M |
Gross Profit | 302.64M |
Operating Income | -78.54M |
Pretax Income | -83.44M |
Net Income | -104.04M |
EBITDA | -7.38M |
EBIT | -78.54M |
Loss Per Share | -$0.82 |
Full Income Statement Balance Sheet
The company has $163.69 million in cash and $411.76 million in debt, giving a net cash position of -$248.08 million or -$1.92 per share.
Cash & Cash Equivalents | 163.69M |
Total Debt | 411.76M |
Net Cash | -248.08M |
Net Cash Per Share | -$1.92 |
Equity (Book Value) | 854.04M |
Book Value Per Share | 6.67 |
Working Capital | 292.43M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $14.05 million and capital expenditures -$33.22 million, giving a free cash flow of -$19.17 million.
Operating Cash Flow | 14.05M |
Capital Expenditures | -33.22M |
Free Cash Flow | -19.17M |
FCF Per Share | -$0.15 |
Full Cash Flow Statement Margins
Gross margin is 43.91%, with operating and profit margins of -11.40% and -15.10%.
Gross Margin | 43.91% |
Operating Margin | -11.40% |
Pretax Margin | -15.30% |
Profit Margin | -15.10% |
EBITDA Margin | -1.07% |
EBIT Margin | -11.40% |
FCF Margin | n/a |
Dividends & Yields
NeoGenomics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.05% |
Shareholder Yield | -1.05% |
Earnings Yield | -15.61% |
FCF Yield | -2.88% |
Dividend Details Analyst Forecast
The average price target for NeoGenomics is $12.14, which is 135.27% higher than the current price. The consensus rating is "Buy".
Price Target | $12.14 |
Price Target Difference | 135.27% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 11.88% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on April 16, 2003. It was a reverse split with a ratio of 1:100.
Last Split Date | Apr 16, 2003 |
Split Type | Reverse |
Split Ratio | 1:100 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |